Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet

被引:35
作者
Flamment, Melissa [1 ]
Gueguen, Naig [1 ,2 ]
Wetterwald, Celine [2 ]
Simard, Gilles [1 ,2 ,3 ]
Malthiery, Yves [1 ,2 ,3 ]
Ducluzeau, Pierre-Henri [1 ,3 ,4 ]
机构
[1] CHU Angers, INSERM, U694, F-49033 Angers, France
[2] CHU Angers, Dept Biochim & Genet, F-49033 Angers, France
[3] Univ Angers, Angers, France
[4] CHU Angers, Dept Endocrinol Diabet Nutr, F-49033 Angers, France
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2009年 / 297卷 / 05期
关键词
cannabinoid receptor; mitochondria; liver; oxidative phosphorylation; ACTIVATED PROTEIN-KINASE; REDUCED FOOD-INTAKE; INDUCED OBESE MICE; RECEPTOR ANTAGONIST; ENERGY-BALANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; RISK-FACTORS; WISTAR RATS; WEIGHT-LOSS;
D O I
10.1152/ajpendo.00169.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Flamment M, Gueguen N, Wetterwald C, Simard G, Malthiery Y, Ducluzeau PH. Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 297: E1162-E1170, 2009. First published September 1, 2009; doi: 10.1152/ajpendo.00169.2009.-The aim of this study was to investigate the effect of rimonabant treatment on hepatic mitochondrial function in rats fed a high-fat diet. Sprague-Dawley rats fed a high-fat diet (35% lard) for 13 wk were treated with rimonabant (10 mg.kg(-1).day(-1)) during the last 3 wk and matched with pair-fed controls. Oxygen consumption with various substrates, mitochondrial enzyme activities on isolated liver mitochondria, and mitochondrial DNA quantity were determined. Body weight and fat mass were decreased in rats treated with rimonabant compared with pair-fed controls. Moreover, the serum adiponectin level was increased with rimonabant. Hepatic triglyceride content was increased, while serum triglycerides were decreased. An increase of mitochondrial respiration was observed in rats treated with rimonabant. The increase of mitochondrial respiration with palmitoyl-CoA compared with respiration with palmitoyl-L-carnitine stating that the entry of fatty acids into mitochondria via carnitine palmitoyltransferase I was increased in rats treated with rimonabant. Moreover, rimonabant treatment led to a reduction in the enzymatic activity of ATP synthase, whereas the quantity of mitochondrial DNA and the activity of citrate synthase remained unchanged. To summarize, rimonabant treatment leads to an improvement of hepatic mitochondrial function by increasing substrate oxidation and fatty acid entry into mitochondria for the beta-oxidation pathway and by increasing proton leak. However, this increase of mitochondrial oxidation is regulated by a decrease of ATP synthase activity in order to have only ATP required for the cell function.
引用
收藏
页码:E1162 / E1170
页数:9
相关论文
共 52 条
[1]   The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake [J].
Addy, Carol ;
Wright, Hamish ;
Van Laere, Koen ;
Gantz, Ira ;
Erondu, Ngozi ;
Musser, Bret J. ;
Lu, Kaifeng ;
Yuan, Jinyu ;
Sanabria-Bohorquez, Sandra M. ;
Stoch, Aubrey ;
Stevens, Cathy ;
Fong, Tung M. ;
De Lepeleire, Inge ;
Cilissen, Caroline ;
Cote, Josee ;
Rosko, Kim ;
Gendrano, Isaias N., III ;
Nguyen, Allison Martin ;
Gumbiner, Barry ;
Rothenberg, Paul ;
de Hoon, Jan ;
Bormans, Guy ;
Depre, Marleen ;
Eng, Wai-Si ;
Ravussin, Eric ;
Klein, Samuel ;
Blundell, John ;
Herman, Gary A. ;
Burns, H. Donald ;
Hargreaves, Richard J. ;
Wagner, John ;
Gottesdiener, Keith ;
Amatruda, John M. ;
Heymsfield, Steven B. .
CELL METABOLISM, 2008, 7 (01) :68-78
[2]   REGULATION OF OXIDATIVE-PHOSPHORYLATION IN THE MAMMALIAN-CELL [J].
BALABAN, RS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :C377-C389
[3]  
Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]
[4]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[5]   CONTROL OF ENERGY TRANSFORMATION IN MITOCHONDRIA ANALYSIS BY A QUANTITATIVE MODEL [J].
BOHNENSACK, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 634 (01) :203-218
[6]   Effects of cannabinoid receptors on skeletal muscle oxidative pathways [J].
Cavuoto, P. ;
McAinch, A. J. ;
Hatzinikolas, G. ;
Cameron-Smith, D. ;
Wittert, G. A. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 267 (1-2) :63-69
[7]   The expression of receptors for endocannabinoids in human and rodent skeletal muscle [J].
Cavuoto, Paul ;
McAinch, Andrew J. ;
Hatzinikolas, George ;
Janovska, Alena ;
Game, Philip ;
Wittert, Gary A. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 364 (01) :105-110
[8]  
Chan DC, 2008, CURR VASC PHARMACOL, V6, P67
[9]   Role of adiponectin in human skeletal muscle bioenergetics [J].
Civitarese, Anthony E. ;
Ukropcova, Barbara ;
Carling, Stacy ;
Hulver, Matthew ;
DeFronzo, Ralph A. ;
Mandarino, Lawrence ;
Ravussin, Eric ;
Smith, Steve R. .
CELL METABOLISM, 2006, 4 (01) :75-87
[10]   Appetite suppression and weight loss after the cannabinoid antagonist SR141716 [J].
Colombo, G ;
Agabio, R ;
Diaz, G ;
Lobina, C ;
Reali, R ;
Gessa, GL .
LIFE SCIENCES, 1998, 63 (08) :PL113-PL117